Sidra Medicine of Qatar Foundation and Qatar’s new hospital for children, young people, and women, will bring together world-leading experts and practitioners from ten countries to share knowledge and research and spur innovation in advanced treatments ranging from cellular, gene therapy, molecular targeted therapies and immunotherapy. The two-day event will begin on Saturday.
The one-of-a-kind event is the latest in the Sidra Symposia Series, a popular programme that has attracted a large following in the country by equipping attendees to practice at the leading-edge of their field through accessing knowledge, ideas and best practice in a wide variety of clinical areas.
The upcoming conference will feature leading figures and experts from the Middle East, Europe and US. Key international speakers at the event include Soldano Ferrone, Faculty member of the Department of Surgery at Massachusetts General Hospital, Harvard Medical School, Adrian Thrasher, Professor of Paediatric Immunology at UCL Great Ormond Street Institute of Child Health, and Michele Maio, Director of the Center for Immuno-Oncology at University Hospital of Siena, amongst many others.
Providing a rich mixture of workshop sessions and keynote lectures, the conference is open to physicians, nurses, pharmacists, allied health providers, medical students and other practitioners who care for patients with oncological, hematological, immunology, inflammatory and autoimmune disorders. Attendance at the symposium provides a major boost to participant’s Continuing Medical Education (CME), since it is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department. Attendees can earn 14.75 CME points.
The conference takes place at the Four Seasons Hotel from 7am to 5pm on Saturday and Sunday. Spaces are filling up fast with limited time for interested parties to secure their attendance. Tickets are available at http://events.sidra.org/event/advanced-therapies-in-healthcare/ A limited number of spaces are available for on-site registration on both days.
Dr Chiara Cugno (pictured), Director of Clinic Research at Sidra Medicine said: “At Sidra, we’re committed to creating effective platforms for healthcare professionals to collaborate, share best practices and methodologies and to developing programs that advance personalized medicine in Qatar and beyond. We look forward to welcoming large numbers of the country’s leading medical practitioners to come together and play their part in accelerating advanced therapy development. This conference is a critical part of our long-term goal to boost the introduction of advanced treatments, especially in cell and gene therapy in Qatar. It goes a long way towards supporting our ambition to introduce ground-breaking technologies and techniques that will significantly improve the lives of children, young people and women in the country.”
The conference will help ongoing research and drive scientific knowledge in the area of translational research and early clinical applications.
Specifically, it will shed light into the development phases, clinical trials, and regulatory aspects of these therapies, particularly in the field of Oncology, Hematology, Immunology, Inflammatory and Autoimmune disorders, to engender better and more personalised treatment options, and ultimately bring important health benefits.
